Netherlands
t 31 20 655 79 28
f 31 20 659 76 73
United Kingdom
t 0800 376 8660
f 0800 279 1117
All Other European
Countries
t 31 (0) 20 659 60 51
f 31 (0) 20 659 76 73
L AT I N AME
1999).
6. Mano, I. and Driscoll, M., Bioessays, 21, 568
(1999).
7. Driscoll, M., Brain Pathol., 6, 411 (1996).
8. Tavernarakis, N. and Driscoll, M., Annu. Rev.
Physiol., 59, 659 (1997).
Anti-BTK, C-terminal is developed in rabbit using a
synthetic peptide corresponding to amino acids 642-
659 of human BTK, conjugated to KLH via an N-
terminal added cystein residue, as immunogen. This
sequence
developed in rabbit using a synthetic peptide
(C)KQIGSLESKLEHLTAS corresponding to amino acid
residues 659–674 of human KCa2.3 as the immunogen.
This sequence has 100% homology with mouse, pig,
and rat. The
activated protein kinase gamma-subunit isoforms
and their role in AMP binding. Biochem. J., 346,
659-669 (2000).
Precisio is a trademark of Sigma-Aldrich
Biotechnology LP and Sigma-Aldrich Co.
nucleosomal function for I-kappa-
B kinase-alpha in NF-kappa-B-dependent gene
expression. Nature, 423, 659-663 (2003).
2. Hoshino, K. et al., I-kappa-B kinase-alpha is critical
for interferon-alpha production
activated protein kinase gamma-subunit isoforms
and their role in AMP binding. Biochem. J., 346,
659-669 (2000).
PRECISIO is a registered trademark of Sigma-Aldrich
Co. LLC.
JR,SV,MAM 04/12-1
receptors on
dopaminergic neurons in the substantia nigra pars compacta of therat. Neuroscience
87:659-673.
Steinlein O, Weiland S, Stoodt J, and Propping P (1996) Exon-intron structure of the
human
)
8. T. Hatai, et al., J. Biol. Chem., 275, 26576 (2000)
9. T. Araki, et al., J. Neurochem., 74, 659 (2000)
10. T. Araki, et al., J. Neurochem., 75, 1502 (2000)
11. Y. Morita, et al., Proc Natl. Acad
result in the loss of your sample.
5. Add 200 µL of freshly prepared Desulfonation Solution to the center of the membrane in
the spin column.
6. Incubate at room temperature for 15 minutes. Centrifuge
major immediate early gene of human
cytomegalovirus. PNAS 81, 659-663. (1984).
5. C.B. Brewer, Methods of Cell Biology 43: 233-245 (1994).
6. Jiminez, A. and Davies, J., Nature 287, 869-871 (1980).
5. Decant and discard supernatant.
6. Estimate the packed cell volume (PCV).
7. Add 1 ml (5× PCV) of Lysis Buffer (including DTT
and protease inhibitors) to 200 µl of PCV.
8. Resuspend the cell pellet
5. Decant and discard supernatant.
6. Estimate the packed cell volume (PCV).
7. Add 1 ml (5× PCV) of Lysis Buffer (including DTT
and protease inhibitors) to 200 µl of PCV.
8. Resuspend the cell pellet
5. Decant and discard supernatant.
6. Estimate the packed cell volume (PCV).
7. Add 1 ml (5× PCV) of Lysis Buffer (including DTT
and protease inhibitors) to 200 µl of PCV.
8. Resuspend the cell pellet
M IP WB IC antiserum Rb IgG 200 µL 06-225
Anti-phospho-c-Jun (Ser63) H M R WB Pur Rb IgG 100 µL 06-828
Anti-phospho-c-Jun (Ser73) H M IP WB IC APur Rb IgG 100 µL 06-659
Anti-phospho-c-Jun (Thr91
J. Biol. Chem., 264, 8222-8229 (1989).
2. Thomsen, D. R., et al., Proc. Natl. Acad. Sci. USA, 81, 659-663 (1984).
Feature Map Position
CMV promoter 166-916
CMV 30 sequencing primer 825-854
J. Biol. Chem., 264, 8222-8229 (1989).
2. Thomsen, D. R., et al., Proc. Natl. Acad. Sci. USA, 81, 659-663 (1984).
Feature Map Position
CMV promoter 166-916
CMV 30 sequencing primer 825-854
J. Biol. Chem., 264, 8222-8229 (1989).
2. Thomsen, D. R., et al., Proc. Natl. Acad. Sci. USA, 81, 659-663 (1984).
Feature Map Position
CMV promoter 166-916
CMV 30 sequencing primer 825-854